| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 66.64% | -6.01% | -0.42% | 32/142 | 52.4% | 佰仁医疗科技 | 88.71% | 行业排名> |
| 2026-03-31 | 66.92% | -5.54% | -4.67% | 32/142 | 52.37% | 佰仁医疗科技 | 88.17% | 行业排名> |
| 2025-12-31 | 70.2% | -2.44% | 0.22% | 22/142 | 51.9% | 佰仁医疗科技 | 89.18% | 行业排名> |
| 2025-09-30 | 70.05% | -3.18% | -1.2% | 25/142 | 52.23% | 佰仁医疗科技 | 88.17% | 行业排名> |
| 2025-06-30 | 70.9% | -2.87% | 0.07% | 21/142 | 52.48% | 佰仁医疗科技 | 88.54% | 行业排名> |
| 2025-03-31 | 70.85% | -4.32% | -1.54% | 21/142 | 52.13% | 佰仁医疗科技 | 85.72% | 行业排名> |
| 2024-12-31 | 71.96% | 1.2% | -0.54% | 20/142 | 53.08% | 佰仁医疗科技 | 88.34% | 行业排名> |
| 2024-09-30 | 72.35% | 2.56% | -0.89% | 20/142 | 53.87% | 佰仁医疗科技 | 88.56% | 行业排名> |
| 2024-06-30 | 73% | 6.86% | -1.42% | 19/142 | 53.95% | 佰仁医疗科技 | 89.27% | 行业排名> |
| 2024-03-31 | 74.05% | 17.31% | 4.14% | 21/142 | 53.88% | 佰仁医疗科技 | 89.28% | 行业排名> |
| 2023-12-31 | 71.11% | 3.73% | 0.8% | 24/142 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 70.54% | 5.37% | 3.26% | 26/142 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 68.31% | 8.71% | 8.22% | 33/142 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 63.12% | -13.69% | -7.92% | 48/142 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 68.55% | -6% | 2.4% | 33/142 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 66.95% | 2% | 6.54% | 38/142 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 62.84% | -15.34% | -14.08% | 50/142 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 73.13% | 2% | 0.28% | 25/142 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 72.93% | -4.26% | -1.74% | 28/142 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-06-30 | 74.22% | 2% | -2.56% | 27/142 | 59.05% | 三友医疗 | 90.29% | 行业排名> |
| 2020-12-31 | 76.17% | 2% | 2% | 26/142 | 60.12% | 正海生物 | 90.78% | 行业排名> |

微信公众号
证券之星APP


